Home  >  Products  >  CNR1 (cannabinoid receptor 1 (brain)) Blocking Peptide (the N terminal of CNR1)(100ug)
CNR1 (cannabinoid receptor 1 (brain)) Blocking Peptide (the N terminal of CNR1)(100ug)

CNR1 (cannabinoid receptor 1 (brain)) Blocking Peptide (the N terminal of CNR1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CNR1 Antibody (ARP59994_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59994
Size: 100ug
Weight: 45kDa
Gene: 1268
Format: Lyophilized powder
Target: This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
Alternative names: CANN6; CB-R; CB1; CB1A; CB1K5; CB1R; CNR
See Full Product Listings >